Kymera Therapeutics, Inc. (KYMR)

NASDAQ: KYMR · Real-Time Price · USD

87.40

+0.90 (1.04%)

At close: Feb 20, 2026, 4:00 PM EST

88.88

+1.48 (1.69%)

After-hours: Feb 20, 2026, 5:24 PM EST

Kymera Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	6,992	2,606	1,413	1,369	3,259	2,748
Market Cap Growth	180.19%	84.43%	3.16%	-57.98%	18.59%	-
Enterprise Value	6,097	1,783	1,059	791	2,666	2,285
Last Close Price	87.40	40.23	25.46	24.96	63.49	62.00
PS Ratio	159.87	55.35	17.98	29.25	44.75	80.75
PB Ratio	6.63	3.12	3.58	2.79	7.09	9.68
P/TBV Ratio	7.39	3.12	3.58	2.79	7.09	9.68
P/FCF Ratio	-	-	-	-	-	34.77
P/OCF Ratio	-	-	-	-	-	31.18
EV/Sales Ratio	139.41	37.87	13.47	16.88	36.61	67.15
EV/FCF Ratio	-	-	-	-	-	28.92
Debt / Equity Ratio	0.09	0.11	0.21	0.04	0.04	0.06
Debt / FCF Ratio	-	-	-	-	-	0.23
Net Debt / Equity Ratio	-0.95	-0.91	-0.89	-1.11	-1.20	-1.55
Net Debt / EBITDA Ratio	2.78	3.04	2.15	3.40	5.55	9.74
Net Debt / FCF Ratio	3.89	3.68	2.56	3.48	4.21	-5.58
Asset Turnover	0.04	0.06	0.13	0.08	0.13	0.11
Quick Ratio	7.07	7.23	4.59	5.74	4.78	2.69
Current Ratio	7.38	7.53	4.73	5.88	4.88	2.73
Return on Equity (ROE)	-32.09%	-36.38%	-33.21%	-32.60%	-26.96%	-28.62%
Return on Assets (ROA)	-19.21%	-20.65%	-17.55%	-16.67%	-11.50%	-9.59%
Return on Capital Employed (ROCE)	-31.90%	-28.20%	-33.80%	-30.30%	-19.60%	-12.30%
Earnings Yield	-4.22%	-8.59%	-10.40%	-11.30%	-3.08%	-1.66%
FCF Yield	-3.29%	-7.96%	-9.72%	-11.39%	-4.01%	2.88%
Buyback Yield / Dilution	-17.82%	-28.58%	-8.22%	-12.39%	-176.60%	-921.45%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q